keyword
https://read.qxmd.com/read/38377518/pharmacogenetic-factors-influence-escitalopram-pharmacokinetics-and-adverse-events-in-youth-with-a-family-history-of-bipolar-disorder-a-preliminary-study
#21
JOURNAL ARTICLE
Duncan C Honeycutt, Thomas J Blom, Laura B Ramsey, Jeffrey R Strawn, Kaitlyn M Bruns, Jeffrey A Welge, Luis R Patino, Manpreet K Singh, Melissa P DelBello
Introduction: Escitalopram is an effective and generally well-tolerated antidepressant, but children of parents with bipolar disorder (BD) may be at increased risk for adverse events associated with antidepressants, including increased irritability, restlessness, impulsivity, and manic symptoms. This risk may be influenced by polymorphisms in genes encoding cytochrome P450 enzymes ( CYP2C19 or CYP2D6 ), the serotonin transporter ( SLC6A4 ), and the serotonin receptor 2A subtype ( HTR2A ). We explored whether gene-drug interactions influence the emergence of adverse events in depressed and/or anxious youth with a family history of BD...
February 2024: Journal of Child and Adolescent Psychopharmacology
https://read.qxmd.com/read/38377253/assessing-pharmacokinetic-correlates-of-escitalopram-related-adverse-drug-reactions
#22
JOURNAL ARTICLE
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
BACKGROUND: To assess the pharmacokinetic correlates of reported adverse drug reactions (ADRs) under antidepressant treatment with escitalopram (ESC) using a large therapeutic drug monitoring database. METHODS: A large naturalistic sample of inpatients and outpatients prescribed ESC was analyzed. ADRs were classified using the Udvalg for Kliniske Undersogelser side effect rating scale. We compared ESC-treated patients with (n = 35) and without ADRs (n = 273) using ESC plasma concentrations as the primary outcome...
February 6, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38376620/nose-to-brain-delivery-of-mirtazapine-via-lipid-nanocapsules-preparation-statistical-optimization-radiolabeling-in-vivo-biodistribution-and-pharmacokinetic-study
#23
JOURNAL ARTICLE
Mennatullah M Ibrahim, Emad B Basalious, Mohamed A El-Nabarawi, Amal Ia Makhlouf, Marwa Eid Sayyed, Ismail Taha Ibrahim
Mirtazapine (MZPc) is an antidepressant drug which is approved by the FDA. It has low bioavailability, which is only 50%, in spite of its rapid absorption when orally administered owing to high first-pass metabolism. This study was oriented towards delivering intranasal (IN) mirtazapine by a direct route to the brain by means of preparing lipid nanocapsules (LNCs) as a targeted drug delivery system. MZP-LNCs were constructed by solvent-free phase inversion temperature technique applying D-Optimal mixture design to study the impact of 3 formulation variables on the characterization of the formulated nanocapsules...
February 20, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38354305/design-synthesis-and-activity-evaluation-of-fluorine-containing-scopolamine-analogues-as-potential-antidepressants
#24
JOURNAL ARTICLE
Le Wang, Xushuo Zhu, Bo Wang, Yijing Wang, Mengqi Wang, Shuping Yang, Chenhe Su, Junbiao Chang, Bo Zhu
This study aimed to develop novel rapid-acting antidepressants with sustained efficacy and favorable safety profiles. We designed and synthesized a series of fluorine-containing scopolamine analogues and evaluated their antidepressant potential. In vitro cytotoxicity assays showed that most of these compounds exhibited minimal toxicity against neuronal and non-neuronal mammalian cell lines (IC50 > 100 μM). The antidepressant activities of the compounds were evaluated using the tail suspension test, and S -3a was identified as a lead compound with potent and sustained antidepressant effects...
February 14, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38353837/mirtazapine-loaded-polymeric-micelles-for-rapid-release-tablet-a-novel-formulation-in-vitro-and-in-vivo-studies
#25
JOURNAL ARTICLE
Sara Nageeb El-Helaly, Amira A Rashad
Major depression is a prevalent disorder characterized by sadness, lack of interest or pleasure, interrupted sleep or food, and impaired concentration. Mirtazapine (MTZ), a tetracyclic antidepressant drug, is commonly used to treat moderate to severe depression. MTZ is classified as a BCS class II drug that has shown bioavailability of 50% due to extensive first-pass metabolism. The aim of this research is to develop a delivery platform with enhanced solubility and oral bioavailability of MTZ through formulating polymeric micelles modeled in a rapid release tablet...
February 14, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38345119/the-place-of-selective-serotonin-reuptake-inhibitors-ssris-in-the-treatment-of-depressive-disorders-in-children-and-adolescents-recommendations-of-the-main-board-of-the-polish-psychiatric-association-part-2-pharmacological-properties-and-safety-of-use
#26
Małgorzata Honorata Janas-Kozik, Agnieszka Słopień, Barbara Remberk, Marcin Siwek
The aim of the study was to review studies evaluating the pharmacodynamic properties of selective serotonin reuptake inhibitors (SSRIs) and their safety. SSRIs in patients <18 years of age sometimes have different pharmacokinetic parameters compared to adults, which has a significant impact on their effectiveness and tolerance. The concentration of fluoxetine, fluvoxamine or paroxetine is about 2 times higher in children compared to adolescents and adults, which should be taken into account at the stage of both drug introduction and setting target doses...
October 31, 2023: Psychiatria Polska
https://read.qxmd.com/read/38319026/insight-into-the-interaction-of-isochroman-with-bovine-serum-albumin-extensive-experimental-and-computational-investigations
#27
JOURNAL ARTICLE
Sana Fatima, Irfan Hussain, Shahbaz Ahmed, Mohd Abuzar Afaq, Mohammad Tabish
The way therapeutic compounds interact with serum protein provides valuable information on their pharmacokinetics, toxicity, effectiveness, and even their structural-related information. Isochroman (IC) is a phytochemical compound obtained from the leaves of Olea europea plant. The derivatives of IC have various pharmacological properties including antidepressants, antihistamines, antiinflammation, anticonvulsants, appetite depressants, etc. The binding of small molecules to bovine serum albumin (BSA) is useful to ensure their efficacy...
February 6, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38299560/pharmacokinetic-correlates-of-clinical-response-in-a-naturalistic-sample-of-escitalopram-treated-patients
#28
JOURNAL ARTICLE
Nicholas Kasperk, Ekkehard Haen, Christoph Hiemke, Thomas Frodl, Georgios Schoretsanitis, Michael Paulzen, Nazar Kuzo
OBJECTIVE: We assessed pharmacokinetic correlates of treatment response to escitalopram using a large therapeutic drug monitoring database. METHODS: A large naturalistic sample of patients receiving escitalopram was analyzed. Responders were defined as 'very much improved' or 'much improved' based on the Clinical Global Impression - Improvement score, CGI-I. We compared responders ( n  = 83) vs. non-responders ( n  = 388) with the primary outcome being the escitalopram plasma concentration and concentration corrected by the daily dose (C/D ratio)...
February 1, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38254341/pharmacokinetics-absolute-bioavailability-and-tissue-distribution-of-wj-14-a-novel-n-methyl-d-aspartate-receptor-antagonist-in-rats-by-liquid-chromatography-tandem-mass-spectrometry
#29
JOURNAL ARTICLE
Weiyin Huang, Yan Zhang, Lishou Yang, Yiwen Zhang, Lei Cheng, Yan Deng, Xinyu Wu, Tingting Wang, Xiaosheng Yang, Linhu Ye
To circumvent the limitations of current antidepressants, WJ-14, a novel N-methyl-d-aspartate receptor antagonist, was synthesized and demonstrated to have remarkable efficiency in the treatment of depression. To illustrate the pharmacokinetics, absolute bioavailability, and tissue distribution of WJ-14 in rats, a rapid and sensitive liquid chromatography-tandem mass spectrometry-based analytical method was developed and validated for the separation and detection of WJ-14 in both plasma and tissue samples. After oral administration, WJ-14 was rapidly absorbed into the blood with time to reach the maximum plasma concentration (Tmax ) within 0...
January 22, 2024: Biomedical Chromatography: BMC
https://read.qxmd.com/read/38243899/a-novel-leu-enkephalin-prodrug-produces-pain-relieving-and-antidepressant-effects
#30
JOURNAL ARTICLE
Lukas Hohenwarter, Ernest Puil, Elham Rouhollahi, Lennart Bohrmann, Shawna Lu, Katayoun Saatchi, Urs O Häfeli, Alasdair Barr, Roland Böttger, K K DurgaRao Viswanadham, Shyh-Dar Li
Persistent pain is a significant healthcare problem with limited treatment options. The high incidence of comorbid chronic pain and depression significantly reduces life quality and complicates the treatment of both conditions. Antidepressants are less effective for pain and depression than for depression alone and they induce severe side effects. Opioids are highly efficacious analgesics, but rapid development of tolerance, dependence, and debilitating side effects limit their efficacy and safe use. Leucine-enkephalin (Leu-ENK), the endogenous delta opioid receptor agonist, controls pain and mood and produces potent analgesia with reduced adverse effects compared to conventional opioids...
February 5, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38242042/essential-oil-of-pterocarpus-santalinus-l-alleviates-behavioral-impairments-in-social-defeat-stress-exposed-mice-by-regulating-neurotransmission-and-neuroinflammation
#31
JOURNAL ARTICLE
Ly Thi Huong Nguyen, Nhi Phuc Khanh Nguyen, Khoa Nguyen Tran, Ho Jin Choi, Il Soo Moon, Heung-Mook Shin, In-Jun Yang
BACKGROUND: Pterocarpus santalinus L. essential oil (PSEO) is traditionally employed for treating fever and mental aberrations. We aim to explore the antidepressant potential of intranasal PSEO in social defeat stress (SDS)-expose mice and identify its mechanisms and components. METHODS: PSEO components were analyzed using gas chromatography-mass spectrometry (GC-MS). C57BL/6 mice underwent a 10-day SDS with intranasal PSEO (10, 20 mg/kg) for 21 days. Efficacy was evaluated through changes in behaviors and serum corticosterone (CORT), hippocampal neurotransmitter, and inflammatory cytokine levels...
January 18, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38220143/changes-in-serum-concentration-of-antidepressants-after-bariatric-surgery-and-recommendations-for-post-bariatric-surgery-antidepressant-therapy
#32
REVIEW
Daniel Maass, Drew Cumming, Haniya Raza, Ted Liao, Joyce Chung, Maryland Pao
OBJECTIVES: Our objectives were to review publicly available data regarding changes in antidepressant serum concentration following bariatric surgery in order to develop medication dosing recommendations in this patient population METHODS: A comprehensive literature review was performed utilizing key search terms in Pubmed. Additional data were retrieved from FDA and DrugBank Online resources. RESULTS: A total of twelve published articles were included in addition to the publicly available data from FDA and DrugBank...
January 12, 2024: Journal of the Academy of Consultation—Liaison Psychiatry
https://read.qxmd.com/read/38219389/an-insight-review-on-the-neuropharmacological-effects-mechanisms-of-action-pharmacokinetics-and-toxicity-of-mitragynine
#33
REVIEW
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, Xiaohui Tong, Rongchun Han, Ebtesam Al-Olayan, Syarul Nataqain Baharum, Hamidun Bunawan, Murni Nazira Sarian, Hamizah Shahirah Hamezah, Ibrahim Jantan
Mitragynine is one of the main psychoactive alkaloids in Mitragyna speciosa Korth. (kratom). It has opium-like effects by acting on μ-, δ-, and κ-opioid receptors in the brain. The compound also interacts with other receptors, such as adrenergic and serotonergic receptors and neuronal Ca2+ channels in the central nervous system to have its neuropharmacological effects. Mitragynine has the potential to treat diseases related to neurodegeneration such as Alzheimer's disease and Parkinson's disease, as its modulation on the opioid receptors has been reported extensively...
January 12, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38217071/pharmacokinetics-of-a-single-transdermal-dose-of-mirtazapine-in-rhesus-macaques-macaca-mulatta
#34
JOURNAL ARTICLE
David W Bissinger, Luke A Wittenburg, Laura M Garzel, Diane E Stockinger, Gregory B Timmel
Decreased appetite is a common clinical problem in captive rhesus macaques ( Macaca mulatta ). Mirtazapine, a tetracyclic antidepressant originally developed for humans, has shown promise as a safe and effective promoter of weight gain and appetite in several veterinary species including rhesus and cynomolgus macaques. Although mirtazapine is available as oral formulations, transdermal delivery in macaques with reduced appetite would allow quick, painless, topical application. Here we describe the pharmacokinetics of a single application of a widely available veterinary transdermal mirtazapine formulation in 6 rhesus macaques...
December 1, 2023: Comparative Medicine
https://read.qxmd.com/read/38197945/age-of-onset-for-increased-dose-adjusted-serum-concentrations-of-antidepressants-and-association-with-sex-and-genotype-an-observational-study-of-34-777-individuals
#35
JOURNAL ARTICLE
Kristine Tveit, Monica Hermann, Roy M Nilsen, Susanna M Wallerstedt, Arvid Rongve, Espen Molden, Kristine Hole
PURPOSE: The aim of this study was to examine the age of onset for increased dose-adjusted serum concentrations (C/D ratio) of common antidepressant drugs and to explore the potential association with sex and CYP2C19/CYP2D6 genotype. METHODS: Serum concentrations and prescribed daily doses for citalopram, escitalopram, sertraline, venlafaxine and mirtazapine, and CYP genotypes, were obtained from a therapeutic drug monitoring (TDM) service. Segmented linear regression analysis was used to examine the relationship between age and antidepressant log C/D ratio in (i) all individuals, (ii) men and women, and (iii) CYP2D6/CYP2C19 normal metabolizers (NMs) and CYP2D6/CYP2C19 intermediate or poor metabolizers (IMs/PMs)...
January 10, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38177696/gm-1020-a-novel-orally-bioavailable-nmda-receptor-antagonist-with-rapid-and-robust-antidepressant-like-effects-at-well-tolerated-doses-in-rodents
#36
JOURNAL ARTICLE
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
The NMDA receptor (NMDAR) antagonist ketamine has shown great potential as a rapid-acting antidepressant; however, its use is limited by poor oral bioavailability and a side effect profile that necessitates in-clinic dosing. GM-1020 is a novel NMDAR antagonist that was developed to address these limitations of ketamine as a treatment for depression. Here, we present the preclinical characterization of GM-1020 alongside ketamine, for comparison. In vitro, we profiled GM-1020 for binding to NMDAR and functional inhibition using patch-clamp electrophysiology...
January 4, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38172482/bioavailability-of-orally-administered-drugs-after-bariatric-surgery
#37
REVIEW
Eliška Dvořáčková, Alena Pilková, Martin Matoulek, Ondřej Slanař, Jan Miroslav Hartinger
PURPOSE OF REVIEW: Oral drug absorption after bariatric surgery is likely to be altered, but the impact of different bariatric surgery procedures on individual drugs is not uniform. The aim of this article is to describe factors influencing the bioavailability of orally administered drugs after bariatric surgery and to provide readers with practical recommendations for drug dosing. We also discuss the medications that may be harmful after bariatric surgery. RECENT FINDINGS: The fundamental factors for enteral drug absorption are the production of gastric acid; the preserved length of the intestine, i...
March 2024: Current Obesity Reports
https://read.qxmd.com/read/38172422/improved-pharmacokinetic-and-pharmacodynamic-profile-of-deuterium-reinforced-tricyclic-antidepressants-doxepin-dosulepin-and-clomipramine%C3%A2-in-animal-models
#38
JOURNAL ARTICLE
Shreyash Moharir, Likhit Akotkar, Urmila Aswar, Dileep Kumar, Bapu Gawade, Kavita Pal, Rajesh Rane
BACKGROUND AND OBJECTIVES: Doxepin, dosulepin, and clomipramine are tricyclic antidepressants (TCAs) that act as serotonin and noradrenaline reuptake inhibitors. The metabolites formed by N-dealkylation of these tricyclic antidepressants contribute to overall poor pharmacokinetics and efficacy. Deuteration of the methyl groups at metabolically active sites has been reported to be a useful strategy for developing more selective and potent antidepressants. This isotopic deuteration can lead to better bioavailability and overall effectiveness...
January 3, 2024: European Journal of Drug Metabolism and Pharmacokinetics
https://read.qxmd.com/read/38161231/novel-radioiodinated-desvenlafaxine-loaded-lipid-nanocapsule-for-brain-delivery
#39
JOURNAL ARTICLE
Veronia R Ayoub, Mona M A Abdel-Mottaleb, Ismail T Ibrahem, Mohamed A Motaleb, Ahmed S Geneidi
Lipid nanocapsules (LNCs) are lipid nanocarriers developed for drug delivery enhancement. The antidepressant drug desvenlafaxine (DSV) was entrapped in LNC to improve its brain delivery. Different DSV-loaded LNCs formulae using different oils and surfactants were studied to obtain the optimum formula for further studies. In vivo biodistribution studies were done using Swiss albino mice by intravenous injection of DSV-loaded LNCs by radioiodination technique. The optimum DSV-loaded LNC formula was obtained by using Labrafil® M1944CS as the oil and Solutol® HS15 as the surfactant in the ratio of 1:1, with a particle size of 34...
December 31, 2023: Archiv der Pharmazie
https://read.qxmd.com/read/38150961/discovery-of-a-cb-2-and-5-ht-1a-receptor-dual-agonist-for-the-treatment-of-depression-and-anxiety
#40
JOURNAL ARTICLE
Wenjiao Yang, Xudong Gong, Haiguo Sun, Chunhui Wu, Jin Suo, Jing Ji, Xiangrui Jiang, Jingshan Shen, Yang He, Haji Akber Aisa
Cannabinoid CB2 R agonists have gained considerable attention as potential novel therapies for psychiatric disorders due to their non-psychoactive nature, in contrast to CB1 R agonists. In this study, we employed molecular docking to design and synthesize 23 derivatives of cannabidiol (CBD) with the aim of discovering potent CB2 R agonists rather than CB2 R antagonists or inverse agonists. Structure-activity relationship (SAR) investigations highlighted the critical importance of the amide group at the C-3' site and the cycloalkyl group at the C-4' site for CB2 R activation...
December 14, 2023: European Journal of Medicinal Chemistry
keyword
keyword
81989
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.